Literature DB >> 25090991

New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Karim R Saab1, Jessica Kendrick1, Joseph M Yracheta2, Miguel A Lanaspa3, Maisha Pollard4, Richard J Johnson5.   

Abstract

African Americans are at increased risk for cardiovascular and metabolic diseases, including obesity, high BP, diabetes, CKD, myocardial infarction, and stroke. Here we summarize the current risks and provide an overview of the underlying risk factors that may account for these associations. By reviewing the relationship between cardiovascular and renal diseases and the African-American population during the early 20th century, the historic and recent associations of African heritage with cardiovascular disease, and modern population genetics, it is possible to assemble strong hypotheses for the primary underlying mechanisms driving the increased frequency of disease in African Americans. Our studies suggest that underlying genetic mechanisms may be responsible for the increased frequency of high BP and kidney disease in African Americans, with particular emphasis on the role of APOL1 polymorphisms in causing kidney disease. In contrast, the Western diet, particularly the relatively high intake of fructose-containing sugars and sweetened beverages, appears to be the dominant force driving the increased risk of diabetes, obesity, and downstream complications. Given that intake of added sugars is a remediable risk factor, we recommend clinical trials to examine the reduction of sweetened beverages as a primary means for reducing cardiovascular risk in African Americans.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  Ethnic minority; chronic kidney disease; hypertension

Mesh:

Substances:

Year:  2014        PMID: 25090991      PMCID: PMC4310665          DOI: 10.1681/ASN.2014040393

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  141 in total

Review 1.  Heart failure in African Americans: a cardiovascular engima.

Authors:  C W Yancy
Journal:  J Card Fail       Date:  2000-09       Impact factor: 5.712

2.  Reactivity as a predictor of subsequent blood pressure: racial differences in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Sarah S Knox; Jeff Hausdorff; Jerome H Markovitz
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

3.  Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors.

Authors:  Michelle E Tarver-Carr; Neil R Powe; Mark S Eberhardt; Thomas A LaVeist; Raynard S Kington; Josef Coresh; Frederick L Brancati
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

4.  Genetic evidence of an early exit of Homo sapiens sapiens from Africa through eastern Africa.

Authors:  L Quintana-Murci; O Semino; H J Bandelt; G Passarino; K McElreavey; A S Santachiara-Benerecetti
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

5.  Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis.

Authors:  D S Ludwig; K E Peterson; S L Gortmaker
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

6.  Loss of urate oxidase activity in hominoids and its evolutionary implications.

Authors:  Masako Oda; Yoko Satta; Osamu Takenaka; Naoyuki Takahata
Journal:  Mol Biol Evol       Date:  2002-05       Impact factor: 16.240

7.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

8.  Hypertensive nephrosclerosis in African Americans versus Caucasians.

Authors:  Carmelita Marcantoni; Li-Jun Ma; Charles Federspiel; Agnes B Fogo
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

9.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

10.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

Authors:  M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  26 in total

1.  Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac Catheterization.

Authors:  Hanghang Wang; Patrick H Pun; Lydia Kwee; Damian Craig; Carol Haynes; Megan Chryst-Ladd; Laura P Svetkey; Uptal D Patel; Elizabeth R Hauser; Martin R Pollak; William E Kraus; Svati H Shah
Journal:  Cardiorenal Med       Date:  2016-12-29       Impact factor: 2.041

Review 2.  Disparities in Hypertension Among African-Americans: Implications of Insufficient Sleep.

Authors:  Naima Covassin; Eddie L Greene; Prachi Singh; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

Review 3.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Authors:  Thomas Jensen; Manal F Abdelmalek; Shelby Sullivan; Kristen J Nadeau; Melanie Green; Carlos Roncal; Takahiko Nakagawa; Masanari Kuwabara; Yuka Sato; Duk-Hee Kang; Dean R Tolan; Laura G Sanchez-Lozada; Hugo R Rosen; Miguel A Lanaspa; Anna Mae Diehl; Richard J Johnson
Journal:  J Hepatol       Date:  2018-02-02       Impact factor: 25.083

Review 4.  Perspective: A Historical and Scientific Perspective of Sugar and Its Relation with Obesity and Diabetes.

Authors:  Richard J Johnson; Laura G Sánchez-Lozada; Peter Andrews; Miguel A Lanaspa
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

5.  Xanthine oxidase inhibition protects against Western diet-induced aortic stiffness and impaired vasorelaxation in female mice.

Authors:  Guido Lastra; Camila Manrique; Guanghong Jia; Annayya R Aroor; Melvin R Hayden; Brady J Barron; Brett Niles; Jaume Padilla; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-05-24       Impact factor: 3.619

6.  Letter by Triantafyllou and Straub Regarding Article, "Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study".

Authors:  Georgios A Triantafyllou; Adam C Straub
Journal:  Circulation       Date:  2017-12-12       Impact factor: 29.690

7.  Neutrophil elastase and myeloperoxidase mRNA expression in overweight and obese subjects.

Authors:  Mohammad Ali; Shahana Jasmin; Mohammad Fariduddin; Sheikh M K Alam; M I Arslan; Subrata K Biswas
Journal:  Mol Biol Rep       Date:  2018-07-28       Impact factor: 2.316

Review 8.  The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.

Authors:  Beje Thomas; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

9.  Tinnitus and its risk factors in african americans: The Jackson Heart Study.

Authors:  Laura House; Charles E Bishop; Christopher Spankovich; Dan Su; Karen Valle; John Schweinfurth
Journal:  Laryngoscope       Date:  2017-11-29       Impact factor: 3.325

10.  APOL1, CDKN2A/CDKN2B, and HDAC9 polymorphisms and small vessel ischemic stroke.

Authors:  R Akinyemi; H K Tiwari; D K Arnett; B Ovbiagele; M R Irvin; K Wahab; F Sarfo; V Srinivasasainagendra; A Adeoye; R T Perry; A Akpalu; C Jenkins; O Arulogun; M Gebregziabher; L Owolabi; R Obiako; E Sanya; M Komolafe; M Fawale; P Adebayo; G Osaigbovo; T Sunmonu; P Olowoyo; I Chukwuonye; Y Obiabo; A Onoja; J Akinyemi; G Ogbole; S Melikam; R Saulson; M Owolabi
Journal:  Acta Neurol Scand       Date:  2017-10-03       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.